Cargando…
Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from convention...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578411/ https://www.ncbi.nlm.nih.gov/pubmed/33133105 http://dx.doi.org/10.3389/fimmu.2020.591669 |
_version_ | 1783598358938517504 |
---|---|
author | Sun, Liguang Jin, Chun-Hui Tan, Shulian Liu, Wentao Yang, Yong-Guang |
author_facet | Sun, Liguang Jin, Chun-Hui Tan, Shulian Liu, Wentao Yang, Yong-Guang |
author_sort | Sun, Liguang |
collection | PubMed |
description | Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from conventional mouse models cannot be applied to humans. The humanized mouse with a functional human immune system, also referred to as human immune system (HIS) mouse, is the only model available to date for in vivo studies in real-time of human immune function under physiological and pathological conditions. HIS mice with human tumor xenografts are considered an emerging and promising in vivo model for modeling human cancer immunotherapy. In this review, we briefly discuss the protocols to construct HIS mice and elaborate their pros and cons. Particular attention is given to HIS mouse models with human tumor that is autologous or genetically identical to the human immune system, which are discussed with examples of their usefulness in modeling human cancer immunotherapies. |
format | Online Article Text |
id | pubmed-7578411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75784112020-10-30 Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies Sun, Liguang Jin, Chun-Hui Tan, Shulian Liu, Wentao Yang, Yong-Guang Front Immunol Immunology Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from conventional mouse models cannot be applied to humans. The humanized mouse with a functional human immune system, also referred to as human immune system (HIS) mouse, is the only model available to date for in vivo studies in real-time of human immune function under physiological and pathological conditions. HIS mice with human tumor xenografts are considered an emerging and promising in vivo model for modeling human cancer immunotherapy. In this review, we briefly discuss the protocols to construct HIS mice and elaborate their pros and cons. Particular attention is given to HIS mouse models with human tumor that is autologous or genetically identical to the human immune system, which are discussed with examples of their usefulness in modeling human cancer immunotherapies. Frontiers Media S.A. 2020-10-08 /pmc/articles/PMC7578411/ /pubmed/33133105 http://dx.doi.org/10.3389/fimmu.2020.591669 Text en Copyright © 2020 Sun, Jin, Tan, Liu and Yang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Sun, Liguang Jin, Chun-Hui Tan, Shulian Liu, Wentao Yang, Yong-Guang Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title | Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title_full | Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title_fullStr | Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title_full_unstemmed | Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title_short | Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies |
title_sort | human immune system mice with autologous tumor for modeling cancer immunotherapies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578411/ https://www.ncbi.nlm.nih.gov/pubmed/33133105 http://dx.doi.org/10.3389/fimmu.2020.591669 |
work_keys_str_mv | AT sunliguang humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies AT jinchunhui humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies AT tanshulian humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies AT liuwentao humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies AT yangyongguang humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies |